Figure 2From: Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma Sequential isotope bone scans of the patient. Isotope bone scans demonstrating response to treatment with reduction in size and number of skeletal metastases when compared to baseline (left panel, A) and 3 months after treatment (right panel, B) with temsirolimus.Back to article page